Research Articles
Cellular Sabotage: How a Chicken Parasite's Hidden Viral Partner Manipulates Its Biology
Discover how the OTU deubiquitinating enzyme in Eimeria tenella interacts with Eimeria tenella virus RDRP, revealing complex molecular relationships in parasite biology.
Monoclonal Antibodies Against Uev1A: Decoding a Cancer Enigma
Explore how monoclonal antibodies are revolutionizing cancer research by targeting the dual-natured Uev1A protein, a key player in cancer progression and suppression.
The Ubiquitin Saboteur: How a Mutant Protein Slowly Strangles Brain Cells
Discover how a mutant form of ubiquitin progressively impairs proteasome function in a dose-dependent manner, contributing to neurodegenerative diseases like Alzheimer's and Parkinson's.
Breaking the Cycle: How Cyclin-Dependent Kinases Power Cancer and the Inhibitors Stopping Them
Explore the science behind cyclin-dependent kinases (CDKs), their role in cancer progression, and the breakthrough inhibitors revolutionizing cancer treatment.
The Tiny Molecule That Could Revolutionize Childhood Eye Cancer Treatment
Discover how miR-218-5p acts as a powerful tumor suppressor in retinoblastoma by targeting NACC1 and inhibiting the AKT/mTOR signaling pathway.
Disarming Bone Cancer: How Hijacking Cellular Recycling Fights Osteosarcoma
Discover how targeting the E3 ubiquitin ligase CBL offers promising new approaches to fight osteosarcoma by reprogramming cellular recycling systems.
Disarming the Body's Saboteur: How Silencing the ITCH Gene Could Revolutionize Pancreatic Cancer Treatment
Exploring how genetic knockdown of ITCH E3 ubiquitin ligase increases pancreatic cancer cell sensitivity to therapeutics through advanced gene-editing techniques.
Rewriting the Brain's Rules: How Targeted Protein Degradation Fights Neurodegenerative Diseases
Explore how Targeted Protein Degradation (TPD) is revolutionizing the treatment of neurodegenerative diseases by eliminating toxic proteins rather than just inhibiting them.
Targeting the MYC Pathway: New Hope for Pancreatic Cancer Treatment
Exploring innovative strategies to target the MYC oncogene for pancreatic cancer treatment, including indirect inhibition, mRNA degradation, and combination therapies.
Hunting Cancer's Kill Switch: How Computer Design and Lab Experiments Are Revolutionizing Cancer Therapy
Exploring the intersection of computational biology and laboratory research in developing protein ligands to induce apoptosis in cancer cells.